BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23907540)

  • 21. PIP4K2A as a negative regulator of PI3K in PTEN
    Shin YJ; Sa JK; Lee Y; Kim D; Chang N; Cho HJ; Son M; Oh MYT; Shin K; Lee JK; Park J; Jo YK; Kim M; Paddison PJ; Tergaonkar V; Lee J; Nam DH
    J Exp Med; 2019 May; 216(5):1120-1134. PubMed ID: 30898893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells.
    Wang MY; Lu KV; Zhu S; Dia EQ; Vivanco I; Shackleford GM; Cavenee WK; Mellinghoff IK; Cloughesy TF; Sawyers CL; Mischel PS
    Cancer Res; 2006 Aug; 66(16):7864-9. PubMed ID: 16912159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implications for immunotherapy of tumor-mediated T-cell apoptosis associated with loss of the tumor suppressor PTEN in glioblastoma.
    Waldron JS; Yang I; Han S; Tihan T; Sughrue ME; Mills SA; Pieper RO; Parsa AT
    J Clin Neurosci; 2010 Dec; 17(12):1543-7. PubMed ID: 20822910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From the Cover: Neutralization of terminal differentiation in gliomagenesis.
    Hu J; Ho AL; Yuan L; Hu B; Hua S; Hwang SS; Zhang J; Hu T; Zheng H; Gan B; Wu G; Wang YA; Chin L; DePinho RA
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14520-7. PubMed ID: 23918370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PTEN Suppresses Glycolysis by Dephosphorylating and Inhibiting Autophosphorylated PGK1.
    Qian X; Li X; Shi Z; Xia Y; Cai Q; Xu D; Tan L; Du L; Zheng Y; Zhao D; Zhang C; Lorenzi PL; You Y; Jiang BH; Jiang T; Li H; Lu Z
    Mol Cell; 2019 Nov; 76(3):516-527.e7. PubMed ID: 31492635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential SKIP expression in PTEN-deficient glioblastoma regulates cellular proliferation and migration.
    Davies EM; Kong AM; Tan A; Gurung R; Sriratana A; Bukczynska PE; Ooms LM; McLean CA; Tiganis T; Mitchell CA
    Oncogene; 2015 Jul; 34(28):3711-27. PubMed ID: 25241900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype.
    Duan S; Yuan G; Liu X; Ren R; Li J; Zhang W; Wu J; Xu X; Fu L; Li Y; Yang J; Zhang W; Bai R; Yi F; Suzuki K; Gao H; Esteban CR; Zhang C; Izpisua Belmonte JC; Chen Z; Wang X; Jiang T; Qu J; Tang F; Liu GH
    Nat Commun; 2015 Dec; 6():10068. PubMed ID: 26632666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway.
    de la Iglesia N; Konopka G; Puram SV; Chan JA; Bachoo RM; You MJ; Levy DE; Depinho RA; Bonni A
    Genes Dev; 2008 Feb; 22(4):449-62. PubMed ID: 18258752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-Tumor Effects of Sodium Meta-Arsenite in Glioblastoma Cells with Higher Akt Activities.
    Lee EJ; Sung JY; Koo KH; Park JB; Kim DH; Shim J; Lee CH; Park J; Kim YN
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.
    Edwards LA; Thiessen B; Dragowska WH; Daynard T; Bally MB; Dedhar S
    Oncogene; 2005 May; 24(22):3596-605. PubMed ID: 15782140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells.
    Guo P; Nie Q; Lan J; Ge J; Qiu Y; Mao Q
    Biochem Biophys Res Commun; 2013 Nov; 441(1):186-90. PubMed ID: 24140063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of podoplanin in human astrocytic brain tumors is controlled by the PI3K-AKT-AP-1 signaling pathway and promoter methylation.
    Peterziel H; Müller J; Danner A; Barbus S; Liu HK; Radlwimmer B; Pietsch T; Lichter P; Schütz G; Hess J; Angel P
    Neuro Oncol; 2012 Apr; 14(4):426-39. PubMed ID: 22394497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma.
    Parsa AT; Waldron JS; Panner A; Crane CA; Parney IF; Barry JJ; Cachola KE; Murray JC; Tihan T; Jensen MC; Mischel PS; Stokoe D; Pieper RO
    Nat Med; 2007 Jan; 13(1):84-8. PubMed ID: 17159987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-1908 functions as a glioblastoma oncogene by suppressing PTEN tumor suppressor pathway.
    Xia X; Li Y; Wang W; Tang F; Tan J; Sun L; Li Q; Sun L; Tang B; He S
    Mol Cancer; 2015 Aug; 14():154. PubMed ID: 26265437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ubiquitin-specific protease 8 links the PTEN-Akt-AIP4 pathway to the control of FLIPS stability and TRAIL sensitivity in glioblastoma multiforme.
    Panner A; Crane CA; Weng C; Feletti A; Fang S; Parsa AT; Pieper RO
    Cancer Res; 2010 Jun; 70(12):5046-53. PubMed ID: 20484045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of epidermal growth factor receptor and phosphatase and tensin homologue gene expression on the inhibition of U87MG glioblastoma cell proliferation induced by protein kinase inhibitors.
    Xing WJ; Zou Y; Han QL; Dong YC; Deng ZL; Lv XH; Jiang T; Ren H
    Clin Exp Pharmacol Physiol; 2013 Jan; 40(1):13-21. PubMed ID: 23110505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.
    Kessler T; Sahm F; Blaes J; Osswald M; Rübmann P; Milford D; Urban S; Jestaedt L; Heiland S; Bendszus M; Hertenstein A; Pfenning PN; Ruiz de Almodóvar C; Wick A; Winkler F; von Deimling A; Platten M; Wick W; Weiler M
    Oncotarget; 2015 Oct; 6(31):31050-68. PubMed ID: 25682871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma.
    Cloughesy TF; Yoshimoto K; Nghiemphu P; Brown K; Dang J; Zhu S; Hsueh T; Chen Y; Wang W; Youngkin D; Liau L; Martin N; Becker D; Bergsneider M; Lai A; Green R; Oglesby T; Koleto M; Trent J; Horvath S; Mischel PS; Mellinghoff IK; Sawyers CL
    PLoS Med; 2008 Jan; 5(1):e8. PubMed ID: 18215105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness.
    de la Iglesia N; Konopka G; Lim KL; Nutt CL; Bromberg JF; Frank DA; Mischel PS; Louis DN; Bonni A
    J Neurosci; 2008 Jun; 28(23):5870-8. PubMed ID: 18524891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PRMT5-PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells.
    Banasavadi-Siddegowda YK; Russell L; Frair E; Karkhanis VA; Relation T; Yoo JY; Zhang J; Sif S; Imitola J; Baiocchi R; Kaur B
    Oncogene; 2017 Jan; 36(2):263-274. PubMed ID: 27292259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.